Global Point-of-Care Food Sensitivity Testing Market Projected to Reach USD 619.2 Billion by 2035

The global Point-of-Care (POC) Food Sensitivity Testing Market is on a remarkable growth trajectory. Valued at USD 201.6 billion in 2025, the market is projected to reach USD 619.2 billion by 2035, registering a robust compound annual growth rate (CAGR) of 11.9% over the forecast period. This growth is fueled by an increasing prevalence of food-related intolerances, rising consumer awareness, and the demand for timely, accurate, and convenient testing solutions.

The market's expansion reflects both clinical and consumer demand for rapid diagnostics. Conditions such as celiac disease, gluten sensitivity, and lactose intolerance are on the rise globally, prompting individuals and healthcare providers to seek reliable point-of-care solutions. Technological advancements in biosensors, lateral flow assays, and portable devices have made these tests more sensitive, user-friendly, and accessible, further accelerating market adoption.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/reports/sample/rep-gb-17623

Dominance of Bio Sensors and Gluten Testing

Among product categories, bio sensors dominate the market, accounting for 48.7% of total revenue in 2025. Bio sensors are praised for their compact design, rapid turnaround time, and seamless integration with digital platforms, enabling real-time detection of allergens. Continuous innovations in nanotechnology and electrochemical sensing have strengthened their position as the preferred diagnostic tool in both hospitals and consumer settings.

Within the source-of-food category, gluten testing leads with an expected 42.5% share of revenue by 2025. The increasing global prevalence of gluten intolerance and celiac disease, coupled with growing awareness of dietary sensitivities, is driving demand. Accurate and timely gluten testing is critical for dietary management and preventive healthcare, making it a focal point in both home-based and hospital-based applications.

Hospitals Lead End-User Adoption

Hospitals are the primary end-users, accounting for 55.6% of total market revenue in 2025. The reliance on hospitals stems from their ability to provide accurate diagnostics, integrate results into patient care pathways, and manage chronic conditions. As healthcare facilities prioritize evidence-based dietary management and patient-centric care, point-of-care food sensitivity tests have become integral tools in clinical settings.

The ease of use, portability, and rapid results offered by these tests make them particularly suitable for hospitals. Their adoption is further strengthened by growing interest in personalized nutrition and preventive healthcare, highlighting the importance of proactive dietary interventions.

Regional Insights and Key Market Drivers

The United States is expected to see significant growth, reaching a market size of USD 619.2 million by 2035 with a CAGR of 11.6%. Rising prevalence of food allergies and intolerances, combined with a supportive regulatory environment, is encouraging manufacturers to introduce innovative testing solutions.

In the United Kingdom, the market is projected to reach USD 29.3 million by 2035 at a CAGR of 12.8%. Health-conscious consumers are driving demand for personalized nutrition, creating opportunities for POC testing.

China is a key market in East Asia, expected to reach USD 41.1 million by 2035, growing at 14.6% CAGR. Rising health awareness and a proactive approach to dietary management are propelling adoption. Japan, emphasizing food safety and public health, is anticipated to achieve USD 26.0 million by 2035 at a CAGR of 14.1%, while South Korea's strong healthcare infrastructure is expected to drive market growth to USD 17.2 million at 13.1% CAGR.

Category-Wise Insights

Within the product category, food sensitivity test kits dominate with a 49% market share in 2025. Their rapid turnaround times allow individuals to identify trigger foods quickly, enabling informed dietary decisions.

In terms of food sources, peanuts lead the market, accounting for 26.5% of total revenue in 2025. Peanut proteins are highly allergenic and trigger immune responses in sensitive individuals, highlighting the need for accurate testing.

Strategies Driving Market Competitiveness

Market players remain competitive through innovation, partnerships, expansion, and strategic acquisitions. Continuous research and development efforts focus on enhancing assay sensitivity, specificity, and usability. Collaborations with research institutions and healthcare organizations enable joint product development and knowledge sharing.

Expanding into emerging markets with rising healthcare infrastructure presents growth opportunities, while mergers and acquisitions help companies access new technologies and intellectual property. Manufacturers also prioritize regulatory compliance, customer education, and competitive pricing to maintain an edge.

Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/point-of-care-food-sensitivity-testing-market

Leading Companies in the Industry

The market features a mix of established and emerging players, including: Thermo Fisher Scientific Inc. (Life Technologies Corporation), Neogen Corporation, YorkTest Laboratories, Alletess Medical Laboratory, Omega Diagnostics Group PLC, ELISA Technologies, Inc., Aesku.Diagnostics GmbH, Immunomic Therapeutics, Inc., Cambridge Nutritional Sciences, and Aimmune Therapeutics.

Notable developments include Eurofins Scientific's December 2024 launch of the SENSI Strip Allergen product line, aimed at identifying allergens in packaged foods. Such innovations reinforce companies' positions and enhance their product portfolios in the growing market.

Future Outlook

From 2012 to 2025, the point-of-care food sensitivity testing market grew at a CAGR of 10%, reaching USD 201.6 billion. Moving forward, the market is forecasted to achieve USD 619.2 billion by 2035 at an anticipated CAGR of 12.5%. Adoption in hospitals, clinics, and diagnostic centers is expanding due to ease of use, rapid results, and integration into patient care.

Technological advancements, including portable devices and rapid diagnostic kits, are making testing solutions more reliable and user-friendly. These developments, coupled with increasing consumer awareness of food sensitivities and preventive healthcare, position the market for sustained growth.

Related Reports:

Canine Dilated Cardiomyopathy Drugs Market: https://www.futuremarketinsights.com/reports/canine-dilated-cardiomyopathy-drugs-market

Interferons Market: https://www.futuremarketinsights.com/reports/interferons-market

3D Surgical Microscope Systems Market: https://www.futuremarketinsights.com/reports/3d-surgical-microscope-systems-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.